These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38931460)

  • 21. Use of biologics for psoriasis in Central and Eastern European countries.
    Rencz F; Kemény L; Gajdácsi JZ; Owczarek W; Arenberger P; Tiplica GS; Stanimirović A; Niewada M; Petrova G; Marinov LT; Kazandhieva J; Péntek M; Brodszky V; Gulácsi L
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2222-30. PubMed ID: 26370506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethnic, Familial, and Religious Identity of Roma Adolescents in Bulgaria, Czech Republic, Kosovo, and Romania in Relation to Their Level of Well-Being.
    Dimitrova R; van de Vijver FJR; Taušová J; Chasiotis A; Bender M; Buzea C; Uka F; Tair E
    Child Dev; 2017 May; 88(3):693-709. PubMed ID: 28319262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wastage of medicines and its financial impact on the healthcare system in the Czech Republic.
    Smejkalová JKJKJKTAL
    Ceska Slov Farm; 2018 Dec; 67(5-6):192-199. PubMed ID: 30871324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.
    Sardanelli F; Aase HS; Álvarez M; Azavedo E; Baarslag HJ; Balleyguier C; Baltzer PA; Beslagic V; Bick U; Bogdanovic-Stojanovic D; Briediene R; Brkljacic B; Camps Herrero J; Colin C; Cornford E; Danes J; de Geer G; Esen G; Evans A; Fuchsjaeger MH; Gilbert FJ; Graf O; Hargaden G; Helbich TH; Heywang-Köbrunner SH; Ivanov V; Jónsson Á; Kuhl CK; Lisencu EC; Luczynska E; Mann RM; Marques JC; Martincich L; Mortier M; Müller-Schimpfle M; Ormandi K; Panizza P; Pediconi F; Pijnappel RM; Pinker K; Rissanen T; Rotaru N; Saguatti G; Sella T; Slobodníková J; Talk M; Taourel P; Trimboli RM; Vejborg I; Vourtsis A; Forrai G
    Eur Radiol; 2017 Jul; 27(7):2737-2743. PubMed ID: 27807699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The mortality of patients with diabetes mellitus using oral antidiabetic drugs in the Czech Republic decreased over the decade of 2003-2013 and came closer to the population average].
    Brož J; Honěk P; Dušek L; Pavlík T; Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S14-20. PubMed ID: 26652960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the pharmaceutical market in Bulgaria innovative?
    Stoimenova A; Stankova M; Samev K; Petrova G
    Boll Chim Farm; 2003 Sep; 142(7):260-3. PubMed ID: 14677267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A drug utilization study to evaluate effectiveness of risk minimization measures for trimetazidine in France, Hungary, Romania and Spain.
    Ehlken B; Toussi M; Samad A; Kaplan S; Domahidy M; de Voogd H; Böhmert S; Silveira Ramos R; Arora D
    J Clin Pharm Ther; 2019 Jun; 44(3):400-408. PubMed ID: 30659627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria.
    Gulácsi L; Rotar AM; Niewada M; Löblová O; Rencz F; Petrova G; Boncz I; Klazinga NS
    Eur J Health Econ; 2014 May; 15 Suppl 1():S13-25. PubMed ID: 24832832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacy Medicines Not Subject to Medical Prescription in Portugal: An Underused Access Opportunity?].
    Martins AP; Gonçalves E; Marcelo A; Vilão S; Aranda Silva J
    Acta Med Port; 2016 Sep; 29(9):542-548. PubMed ID: 28060692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Navigating Gene Therapy Access: The Case of Bulgaria in the Context of the EU Regulatory Landscape.
    Kostadinov K; Marinova Y; Dimitrov K; Hristova-Atanasova E; Iskrov G; Stefanov R
    Healthcare (Basel); 2024 Feb; 12(4):. PubMed ID: 38391833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USA.
    Ravela R; Lyles A; Airaksinen M
    BMC Health Serv Res; 2022 Jul; 22(1):940. PubMed ID: 35869486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital reforms in 11 Central and Eastern European countries between 2008 and 2019: a comparative analysis.
    Dubas-Jakóbczyk K; Albreht T; Behmane D; Bryndova L; Dimova A; Džakula A; Habicht T; Murauskiene L; Scîntee SG; Smatana M; Velkey Z; Quentin W
    Health Policy; 2020 Apr; 124(4):368-379. PubMed ID: 32113666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility to tobacco use and associated factors among youth in five central and eastern European countries.
    Polanska K; Znyk M; Kaleta D
    BMC Public Health; 2022 Jan; 22(1):72. PubMed ID: 35016662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Young women's constructions of the HPV vaccine: a cross-cultural, qualitative study in Scotland, Spain, Serbia and Bulgaria.
    Gray Brunton C; Farver I; Jäger M; Lenneis A; Parve K; Patarcic D; Petrova D; Hogg R; Kennedy C; Garcia-Retamero R; Todorova I
    Int J Behav Med; 2014 Feb; 21(1):11-9. PubMed ID: 24092427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of patients' access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece.
    Seitaridou Y; Tsekov I; Kamusheva M; Dimitrova M; Petrova G
    Expert Rev Pharmacoecon Outcomes Res; 2022 Mar; 22(2):241-246. PubMed ID: 34525887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs.
    Bencina G; Chami N; Hughes R; Weston G; Baxter C; Maciejczyk A; Popovic L; Karamousouli E; Salomonsson S
    J Med Econ; 2023; 26(1):254-261. PubMed ID: 36756852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondhand smoke presence in outdoor areas in 12 European countries.
    ; Henderson E; Lugo A; Liu X; Continente X; Fernández E; López MJ; Gallus S
    Environ Res; 2021 Apr; 195():110806. PubMed ID: 33515582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Availability of Oral Formulations Labeled for Use in Young Children in Serbia, Germany and the USA.
    Bajcetic M; Kearns GL; Jovanovic I; Brajovic M; van den Anker JN
    Curr Pharm Des; 2015; 21(39):5668-73. PubMed ID: 26323413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The COVID-19 Pandemic in Romania: A Comparative Description with Its Border Countries.
    Enciu BG; Tănase AA; Drăgănescu AC; Aramă V; Pițigoi D; Crăciun MD
    Healthcare (Basel); 2022 Jun; 10(7):. PubMed ID: 35885750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries.
    Lukačišinová A; Reissigová J; Ortner-Hadžiabdić M; Brkic J; Okuyan B; Volmer D; Tadić I; Modamio P; Mariño EL; Tachkov K; Liperotti R; Onder G; Finne-Soveri H; van Hout H; Howard EP; Fialová D
    BMC Geriatr; 2024 Mar; 24(1):240. PubMed ID: 38454372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.